DNAprint Genomics (DNAG)

[ann441j]

From DNAP's website:

STATINOME

STATINOME is a genetic test that measures a patient’s likelihood to develop myalgia as an adverse response to the commonly prescribed Statins Lipitor¹ and Zocor². Myalgia is a Statin side-effect condition characterized by muscle pain, and is a first symptom of the potentially fatal muscle-wasting disease rhabdomyolysis. Though only 1 in every 10,000 patients experiences rhabdomyolysis, about 1% of Lipitor¹ and Zocor² users experience its precursor myalgia. Bayers Statin Baycol³ was recently withdrawn from the market due to an unacceptable fatality rate due to rhabdomyolysis.

1-Lipitor is a registered trademark of Pfizer.

2-Zocor is a registered trademark of Merck.

3-Baycol is a registered trademark of Bayer Corporation.

Ann